There's a wide range of ages when it comes to the Roblox generation and I speak from experience as a librarian having to ...

Recent findings of a drug trial tested an effective gene therapy that slows down the progression of Huntington’s disease by 75% compared to not receiving the therapy. Huntington’s disease occurs ...

Roblox has a plethora of unique and innovative games that are worth experiencing. But which games have caught the eyes of the players the most? If you want to find out, check out this list of the top ...

What is Roblox? ROBLOX is an online virtual playground and workshop, where kids of all ages can safely interact, create, have fun, and learn. It’s unique in that practically everything on ROBLOX is ...

Now that the verdict in Sean "Diddy" Combs' federal criminal trial has come down, the main thing that's left for the mogul is his sentencing. He was found guilty on two counts of transportation to ...

Paul McCartney opened his new round of Got Back tour dates with a surprising John Lennon song. The setlist dug deep into McCartney's Beatles, Wings and solo catalog with wistful selections honoring ...

A complex genetic procedure offers new hope in the fight against one of the world’s cruellest diseases. The single-dose gene therapy has been shown to dramatically slow the relentless, destructive ...

AI music company Suno has launched Suno Studio, a new platform it bills as the world’s first generative Digital Audio Workstation (DAW). The tool integrates AI music generation directly into a ...

Syracuse, N.Y. — Nurse Norma Anne Fitzgerald texted the young mother to remind her she would be visiting the next day to check on her 6-year-old son, who had severe disabilities. She had done that ...

Tim is an Australian Senior Editor based in Germany who has been passionate about video games since he first picked up a PlayStation 1 controller to play Crash Bandicoot as a kid. He started out with ...

We examined 6975 patients with chronic heart failure enrolled in the Gruppo Italiano per lo Studio della Streptochinasi nell'Infarto Miocardico-Heart Failure (GISSI-HF) trial (3.9 years follow-up).